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Abstract
Background: The expression of human milk for later use is on the rise. Bottle systems are used
to deliver the expressed milk. Research has shown that storage of both human milk and artificial
baby milk, or infant formula, leads to a loss of ascorbic acid (commonly called Vitamin C). As milk
is removed from the bottle during feeding and replaced by ambient air, it is unknown if loss of
ascorbic acid occurs during the course of a feeding. The purpose of this study is to investigate the
effect of the milk delivery system on levels of ascorbic acid in human milk and infant formula. The
objectives are to 1) determine changes in ascorbic acid concentration during a 20 minute "feed," 2)
determine if there is a difference in ascorbic acid concentration between delivery systems, and 3)
evaluate if any differences are of clinical importance.
Methods: Commonly available bottles were used for comparison of bottle delivery systems.
Mature human milk was standardized to 42 mg/L of ascorbic acid. Infant formula with iron and infant
formula with docosahexanoic acid were used for the formula samples. Each sample was analyzed
for ascorbic acid concentration at baseline (0), 5, 10, 15, and 20 minutes. Each collection of samples
was completed in triplicate. Samples were analyzed for ascorbic acid using normal-phase high
performance liquid chromatography.
Results: Ascorbic acid concentration declined in all bottle systems during testing, Differences
between the bottle systems were noted. Ascorbic acid concentrations declined to less than 40%
of recommended daily intake for infants in 4 of the bottles systems at the 20 minute sampling.
Conclusion:  The bottle systems used in this study had measurable decreases in the mean
concentration of ascorbic acid. More research is needed to determine if the observed decreases
are related to lower plasma ascorbic acid concentration in infants exclusively bottle fed. The
decrease of ascorbic acid concentration observed in both human milk and infant formula using
varied milk delivery systems may be of clinical importance. For infants who rely solely on bottle
feeds there may be increased risk of deficiency. Bottle shape, size, and venting should be
considered.
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Background
According to the US Department of Labor, as of March of
2006, 75.3% of women were employed outside the home
[1]. Changes in lifestyle and economic activities of lactat-
ing mothers have led to an increase in the expression of
human milk for later use [2]. Often a bottle system is used
to deliver the expressed milk to the infants. While breast-
feeding is consistently recommended as the best choice
for infant nutrition, the expression, handling, storing, and
subsequent provision of human milk to infants intro-
duces the possibility of contamination and nutrient dete-
rioration. Recommendations for human milk handling
and storing are typically made to prevent bacterial growth
[3,4] rather than maintaining the nutritional quality.
Handling and storing of milk introduces the possibility of
oxidation and/or degradation of sensitive nutrients such
as Vitamin C (ascorbic acid) [5].
The L-enantiomer of ascorbic acid, commonly known as
vitamin C, is a nutrient whose deficiency causes the dis-
ease scorbuticus (scurvy). This essential nutrient is critical
to the health and development of infants as it is necessary
for the synthesis of collagen, an important structural com-
ponent of blood vessels, tendons, ligaments, and bone
which develop rapidly during infancy [6]. Ascorbic acid is
also a highly effective antioxidant. Even in small amounts
it can protect indispensable molecules in the body, such
as proteins, lipids, and nucleic acids from damage by free
radicals and reactive oxygen species that are generated
during normal metabolism and rapid growth. Ascorbic
acid is known to spare vitamin E (tocopherols and tocot-
rienols) [7], which is another essential nutrient required
by infants for healthy development.
Ascorbic acid is water soluble, and not stored in the body,
making regular intake necessary to prevent scurvy. The
ascorbic acid content of food is strongly influenced by
handling and storing practices [8]. One reported case of
parents boiling milk, which causes a loss of ascorbic acid,
provided a dramatic example of scurvy in a toddler [9].
Losses of ascorbic acid during the handling and storage of
human milk have been studied. In one report, storage at
both refrigerator and freezer temperatures led to a signifi-
cant decrease in the antioxidant capacity of breast mil
[10]. In related reports, total ascorbic acid levels decreased
on average by one-third after 24 hours of storage at 4°C,
with wide variations between individuals (6 to 76% and 3
to 100%, respectively with N = 11) [11]. Researchers have
investigated the effect of storage on quality and oxidative
sensitivity of human milk [12]. Further, storage of human
milk and infant formula leads to the formation of lipid
peroxidation products, such as lipid peroxides, conju-
gated dienes, and aldehyde breakdown products [13].
These studies indicate that stored human milk and infant
formula are susceptible to nutritional degradation and
loss of specific nutrients.
It is unknown how much loss of ascorbic acid may occur
during the course of a feeding when using a bottle to
deliver the milk to an infant. Many women do use bottles
to provide expressed human milk to their infants. As milk
is removed from a bottle by the suckling infant, ambient
air moves into the bottles and through the milk, creating
bubbles. It is possible that degradation of ascorbic acid
occurs during this process.
The purpose of this study was to investigate the effects of
the milk delivery system on levels of ascorbic acid in
human milk and infant formula with seven commonly
used bottles. The objectives were 1) to determine if there
is a decrease in concentration of ascorbic acid during a 20
minute time period, 2) to evaluate any difference in ascor-
bic acid concentration between bottle delivery systems,
and 3) to evaluate, if any, whether differences in ascorbic
acid concentrations are of clinical importance to infants'
nutrition.
Methods
Delivery systems
These seven commonly used bottle systems were com-
pared: the Avent® Natural (AN) bottle, the BornFree™(BF)
bottle, the Dr. Brown's Natural Flow®(DB) bottle, the
Evenflo® Elan (EL), the Gerber® Classic(G), the Playtex®
Drop-Ins (PD) bottle, and the Playtex Ventaire®(V) bottle
were used for the comparisons. The AN, DB, EL, G, and V
bottles were made of polycarbonate. The BF bottle was
made of glass and the PD had a pre-sterilized disposable
plastic liner. A glass screw-top bottle of similar shape and
size was used as a Control. The diameter of each bottle
was measured in millimeters at the milk-to-air interface
with 100 ml of milk (at baseline – 0 minutes) in the bot-
tles using General Calipers. Surface area of the milk-to-air
interface was approximated using πr2 based on the diam-
eter measurement. The headspace at baseline was approx-
imated using the total volume minus 100 ml (amount of
milk at baseline in each bottle).
Milk samples
Pooled, mature human milk donated by anonymous vol-
unteers was used for the human milk samples. A sample
of the pooled milk was analyzed for ascorbic acid concen-
tration. Stock solution of ascorbic acid was added to the
pooled milk to standardize the ascorbic acid concentra-
tion to 42 mg/L. Infant formulas, one with high iron and
one with docosahexaenoic acid were used for the formula
samples. All samples were brought to 25°C in a water
bath before sampling. Each bottle was sampled at baseline
and at four time points. Except for the Control bottle, the
same commercially available electric pumps were used toInternational Breastfeeding Journal 2008, 3:19 http://www.internationalbreastfeedingjournal.com/content/3/1/
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extract the fluid from the bottles and simulate infant suck-
ling. The pumps were adjusted to deliver the milk at five
ml/min. As the milks were delivered through the seven
bottles, samples of milk were collected at baseline, and
every five minutes for 20 minutes using a sterile pipette.
As samples were collected, an aliquot was dispensed into
a labelled collection tube. The Control sample of each
type of milk was placed in a separate clear glass bottle and
capped. Samples were collected from the control bottle of
milk via sterile pipette at baseline and every five minutes
in the same manner as the pumped milk and an aliquot
was placed into labelled collection tubes. Each sample
collection was completed in triplicate. The collected frac-
tions of milk were protected from light, flushed with
nitrogen, quick frozen in liquid nitrogen, and stored at -
80°C until extracted.
The milk fractions were protected from light, thawed to
approximately 22°C in a water bath, and then mixed. The
samples were extracted as previously described [14].
Briefly, in time intervals of five minutes 300 μl of each
milk sample was placed in a micro centrifuge tube. 800 μl
of 100 mM DL-Dithiothreitol was added and mechani-
cally mixed by inversion for 30 seconds. The samples were
incubated at room temperature for 15 minutes. 300 μl of
0.56% meta-phosphoric acid was added and mechanically
shaken for 30 seconds and centrifuged at 10°C (10 min,
3000 × g) in amber eppendorf tubes. The mixture was fil-
tered into amber glass vials and stored at -20°C until
injection for normal-phase HPLC analysis.
Analytical methods
Isocratic chromatographic separation was carried out
using a mobile phase of Milli-Q water with acetic acid
(0.1%, v/v) and methanol in a relative proportion of 95:5
(v/v) using all HPLC grade reagents. 1 ul of filtrate was
injected by a WPS-3000 auto-sampler (Dionex) onto a
Polar Advantage II (C18 3 um, 4.6 × 150 mm, Dionex)
equipped with a guard column (PAII C18, 5 um, 4.3 × 10
mm, Dionex) and chromatographed on the Ultimate
3000 HPLC (Dionex) using the LPG-3000 loading pump
in conventional HPLC mode. Ascorbic acid was identified
by comparing the retention time of the sample peak to the
peak from the ascorbic acid standard at 254 nm.
Statistical analysis
All values were entered into a Microsoft Excel spreadsheet.
The mean of each triplicate sample set was calculated. The
mean values were used to calculate the amount of ascorbic
acid in milligrams per liter of milk. Standard deviation
and percentage of baseline was calculated for each mean
value. Analysis of variance was used to determine signifi-
cant differences in ascorbic acid levels for the time periods
being studied and to analyze the association with head-
space and milk-to-air interface. Alpha error was set at p <
0.01 for all tests.
Results
Delivery systems
Not all the bottles were consistently shaped. Therefore,
the headspace volume and the milk-to-air interface area
were best approximations. The diameter of the bottles var-
ied from 50 mm to 67 mm as seen in Table 1. The head-
space ranged from a high of 205 ml to a low of 66 ml. The
headspace for the BF, Control, and DB and was statisti-
cally significantly different from the other bottles. The sur-
face area of the milk-to-air interface was higher for AN, BF,
EL, and PD than the other bottles and statistically showed
significant differences. As the bottles were tipped to allow
milk to flow out, the milk-to-air interface increased as an
ellipse formed. As the milk was removed from the Control
bottle via pipette, no bubbles formed on the milk-to-air-
interface.
Milk samples
The mean concentrations of ascorbic acid measured in the
human milk samples, as seen in Table 2, are reported in
milligrams per liter. The baseline values did not show sta-
tistically significant differences between groups. All milk
samples had baseline mean concentrations of ascorbic
acid between 41.87 and 42.66 mg/L. Mean concentrations
of ascorbic acid in human milk from all bottles except
Table 1: Bottle measurements for diameter, headspace, and milk-to-air interface
Delivery system Diameter
 (mm)
Headspace
 (ml)
Milk-to-air interface
 (cm2)
Gerber (G) 52 176 21.23
Ventaire (V) 54 183 22.89
Dr. Brown's (DB) 50 66* 19.63
Elan (EL) 67 180 35.24*
BornFree (BF) 65 127* 33.17*
Playtex Drop-Ins (PD) 56 158 24.62*
Avent Natural (AN) 66 205 34.19*
Control 52 74* 20.42
*Statistically significant at p < 0.01International Breastfeeding Journal 2008, 3:19 http://www.internationalbreastfeedingjournal.com/content/3/1/
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Control, were significantly different from baseline to 20
minutes. At 20 minutes the bottle systems had mean con-
centrations of ascorbic acid between 31.83 and 0.49 mg/
L, compared to 38.32 mg/L in the Control. This is a signif-
icant decrease in ascorbic acid concentration, with a range
from 76% to 1% of baseline values, respectively. The Con-
trol varied by less than 10% from the baseline value main-
taining 91% of the mean concentration of ascorbic acid at
the 20 minute time point.
The mean concentration of ascorbic acid in human milk
infant formula with iron, and infant formula with docosa-
hexaenoic acid is reported in Figures 1, 2, and 3 as a per-
centage of the baseline level derived from the mean values
of the triplicate samples for ease of comparison across and
between groups. In all the bottle systems ascorbic acid did
decline from baseline levels through the 20 minute sam-
ples, with a marked decline in three bottle systems (Fig-
ures 1, 2, and 3). For the human milk samples at five
minutes, all ascorbic acid levels retained at least 82% of
baseline levels. At the 10 minute time point the mean con-
centration of ascorbic acid decreased significantly below
baseline for the AN, BF, EL, G, PD, and V bottles (Figure
1). At the 15 minute time point all bottles, except for the
Control, had mean concentration decreases of up to 77%
compared to baseline. Similar trends were seen for infant
formula with iron and for infant formula with docosahex-
aenoic acid (Figures 2 and 3). At the 20 minute time point
AN, BF, EL, G, and PD were all below 40% of baseline
mean concentrations as seen in Figures 1, 2, and 3. The
Control contained a mean ascorbic acid concentration of
greater than 90% of the baseline concentration at the 20
minute sampling.
Discussion
While the material for most of the bottles was polycar-
bonate, except for the BF and the PD, the bottles used in
this study were quite different from each other in the way
Table 2: Mean ascorbic acid concentration in human milk delivered by bottle in milligrams per liter of milk with standard deviation in 
(SD)
Bottle system 0 minutes 5 minutes 10 minutes 15 minutes 20 minutes
Gerber (G) 41.93 (0.05) 36.19 (0.18) 26.85* (2.17) 16.57* (3.32) 10.33* (3.07)
Ventaire (V) 41.95 (2.02) 39.06 (0.14) 32.90* (2.61) 29.22* (2.97) 22.87* (0.44)
Dr. Brown's (DB) 41.87 (0.83) 39.22 (1.08) 38.82 (1.09) 36.49* (4.21) 31.83* (3.06)
Elan (EL) 42.12 (3.81) 37.51 (1.76) 19.22* (2.06 8.62* (1.99) 0.49* (0.23)
BornFree (BF) 42.54 (4.83) 36.15 (1.00) 30.68* (2.01) 18.42* (3.53) 12.27* (2.92)
Playtex Drop-Ins (PD) 42.66 (2.67) 30.58 (4.60) 21.44* (1.87) 13.96* (3.39) 0.77* (0.30)
Avent Natural (AN) 42.44 (3.05) 34.59 (3.89) 24.71* (1.56) 18.52* (3.78) 3.90* (2.07)
Control 41.98 (0.05) 40.93 (0.66) 40.53 (0.58) 39.39 (1.58) 38.32 (2.27)
*Statistically significant at p < 0.01
Changes in mean ascorbic acid concentration in human milk Figure 1
Changes in mean ascorbic acid concentration in 
human milk. Triplicate samples of human milk, standard-
ized to 42 mg/L of ascorbic acid at baseline, were collected. 
The samples were analyzed for ascorbic acid using normal-
phase high performance liquid chromatography and com-
pared to a standard curve. The mean concentrations for each 
triplicate sample were calculated at baseline, 5, 10, 15, and 20 
minutes. Results represent the mean values (± SD) of three 
experiments displayed as a percent of the baseline level.
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Changes in mean ascorbic acid concentration in infant for- mula with iron Figure 2
Changes in mean ascorbic acid concentration in 
infant formula with iron. Triplicate samples of infant for-
mula with iron were collected. The samples were analyzed 
for ascorbic acid using normal-phase high performance liquid 
chromatography and compared to a standard curve. The 
mean concentrations for each triplicate sample were calcu-
lated at baseline, 5, 10, 15, and 20 minutes. Results represent 
the mean values (± SD) of three experiments displayed as a 
percent of the baseline level.
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that air was replaced in the bottle as milk was removed. EL
and V had removal screw-off bottoms with a diaphragm
designed, according to the manufacturers, to prevent bub-
bles from forming in the milk. The BF bottle had a small
venting system inside the collar of the nipple, which
according to the manufacture, aids in preventing colic.
Bubbles rapidly formed on the milk-to-air interface in the
AN, BF, EL, G, PD, and V bottles as the milk was removed.
No bubbles formed in the Control or the DB bottles.
The milk-to-air interface compared to the amount of
headspace appeared to have a greater impact on the
decrease of ascorbic acid levels than the amount of head-
space. While Gliguem et al reported that the oxygen in the
headspace of packaging was associated with degradation
of ascorbic acid in stored milk [15], the headspace in the
bottles did not correlate with the greatest decreases in
mean ascorbic acid concentration. Those bottles with the
largest milk-to-air interface did have the greatest decreases
in mean concentration of ascorbic acid over time. The air
moving through the milk and the formation of bubbles
on the surface of the milk may be factors in the observed
decreases of ascorbic acid concentration given that the
Control had neither air moving through the milk nor bub-
bles forming on the surface. The Control bottle had the
highest ascorbic acid concentration at 20 minutes.
Conclusion
Infants require approximately 180 mL of human milk
each day for each kilogram of body weight (180 mL/kg/
day) [16]. The Food and Nutrition Board at the Institute
of Medicine recommends an ascorbic acid intake for
healthy infants aged 0 – 6 months of 40 mg/day and 50
mg/day for healthy infants age 6 months to 1 year [17],
which in human milk equates to an estimated intake of
ascorbic acid of 4 mg/100 mL of milk or approximately
7.2 mg/kg of body weight [18]. During the first 6 months
of life most infants are able to meet this requirement by
consuming human milk fed directly from the breast.
Given the decreases in mean ascorbic acid concentrations
observed in this study, an infant relying solely on either
expressed human milk or infant formula that is delivered
via a bottle there may be an increased risk of low intake of
ascorbic acid. More research is needed to validate these
findings as children with low intakes of ascorbic acid are
more vulnerable to develop frequent and more severe
common day-to-day infections [19].
Adults, as well as infants, rely on food for adequate ascor-
bic acid intake. It has been shown that adults who con-
sume food containing ascorbic acid have increases in
circulating concentrations of ascorbic acid within three
hours. Sanchez-Moreno et al suggested that this increase
in circulating ascorbic acid may play a role in the reduc-
tion seen in the formation of harmful compounds pro-
duced by oxidation reactions [20]. Heinonen et al
reported that the plasma concentrations of ascorbic acid
in a group of <32 week-gestation premature infants
declined rapidly in the first three weeks of life [21]. These
infants were fed pooled pasteurized human milk. In other
studies, premature infants receiving formula had low
plasma ascorbic acid concentrations [22,23]. Studies such
as these underscore the importance of consistent intake of
ascorbic acid, particularly in fragile populations such as
premature infants being bottle-fed. The bottle systems
used in this study had measurable decreases in the mean
concentration of ascorbic acid over the 20 minute sam-
pling period. More research is needed to determine if the
observed decreases in ascorbic acid are related to plasma
ascorbic acid concentration in infants exclusively bottle
fed. Bottle shape, size, and venting (no air moving
through the milk and no bubbles forming on the milk)
should be considered when choosing a bottle system for
infant feeding. Further research is needed regarding the
handling and delivery of human milk with regard to pre-
serving the integrity of specific nutrients.
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